Nkarta (NKTX) News Today → AI's Next Magnificent Seven (From The Oxford Club) (Ad) Free NKTX Stock Alerts $6.62 +0.02 (+0.30%) (As of 03:58 PM ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative June 3, 2024 | americanbankingnews.comShort Interest in Nkarta, Inc. (NASDAQ:NKTX) Rises By 16.0%June 3, 2024 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Short Interest UpdateNkarta, Inc. (NASDAQ:NKTX - Get Free Report) saw a large increase in short interest in May. As of May 15th, there was short interest totalling 8,040,000 shares, an increase of 16.0% from the April 30th total of 6,930,000 shares. Based on an average trading volume of 1,000,000 shares, the short-interest ratio is currently 8.0 days.May 18, 2024 | morningstar.comNkarta Inc Ordinary SharesMay 13, 2024 | marketbeat.comNeedham & Company LLC Cuts Nkarta (NASDAQ:NKTX) Price Target to $13.00Needham & Company LLC dropped their price objective on shares of Nkarta from $15.00 to $13.00 and set a "buy" rating for the company in a report on Monday.May 13, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Price Target Increased to $23.00 by Analysts at HC WainwrightHC Wainwright raised their price objective on shares of Nkarta from $22.00 to $23.00 and gave the stock a "buy" rating in a report on Monday.May 10, 2024 | finance.yahoo.comNkarta Inc (NKTX) Reports Q1 2024 Earnings: A Detailed Financial and Operational AnalysisMay 10, 2024 | finanznachrichten.deNkarta, Inc.: Nkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsMay 10, 2024 | markets.businessinsider.comNkarta Inc. Buy Rating Affirmed Amidst Promising Clinical Studies and Robust Financial HealthMay 10, 2024 | markets.businessinsider.comBuy Rating Affirmed: Nkarta’s NKX019 Shows Promise in Lupus Nephritis Clinical TrialsMay 10, 2024 | investorplace.comNKTX Stock Earnings: Nkarta Beats EPS for Q1 2024May 9, 2024 | finance.yahoo.comNkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsMay 9, 2024 | globenewswire.comNkarta Reports First Quarter 2024 Financial Results and Corporate HighlightsMay 7, 2024 | investorplace.comOpportunity Alert: 3 Undiscovered Stocks About to Explode on Wall Street's RadarApril 27, 2024 | msn.comAmgen’s Blincyto data send Cullinan higherApril 27, 2024 | seekingalpha.comNkarta: Down 50% Since March With A Clinical Catalyst AheadApril 18, 2024 | finance.yahoo.comNkarta, Inc. (NKTX) Interactive Stock Chart - Yahoo FinanceApril 10, 2024 | markets.businessinsider.comAnalysts Offer Insights on Healthcare Companies: Evolus (EOLS) and Nkarta (NKTX)April 10, 2024 | markets.businessinsider.comAnalysts Are Bullish on Top Healthcare Stocks: Abivax SA Sponsored ADR (ABVX), Arcutis Biotherapeutics (ARQT)April 10, 2024 | marketbeat.comNeedham & Company LLC Reiterates Buy Rating for Nkarta (NASDAQ:NKTX)Needham & Company LLC reissued a "buy" rating and set a $15.00 price objective on shares of Nkarta in a report on Wednesday.April 8, 2024 | businesswire.comGlancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of InvestorsApril 5, 2024 | businesswire.comINVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of InvestorsApril 5, 2024 | businesswire.comThe Law Offices of Frank R. Cruz Announces Investigation of Nkarta, Inc. (NKTX) on Behalf of InvestorsApril 3, 2024 | globenewswire.comNkarta to Participate in Upcoming Investor ConferencesApril 2, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Stock Price Down 5.7%Nkarta (NASDAQ:NKTX) Stock Price Down 5.7%April 1, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Shares Gap Up to $10.81Nkarta (NASDAQ:NKTX) Shares Gap Up to $10.81March 31, 2024 | 247wallst.comHuge Insider Buying From Buffett, an NFL Team Owner, a New CEOMarch 30, 2024 | insidertrades.comSimeon George Purchases 2,000,000 Shares of Nkarta, Inc. (NASDAQ:NKTX) StockMarch 28, 2024 | marketbeat.comNkarta, Inc. (NASDAQ:NKTX) Director Acquires $20,000,000.00 in StockNkarta, Inc. (NASDAQ:NKTX - Get Free Report) Director Simeon George bought 2,000,000 shares of the business's stock in a transaction on Wednesday, March 27th. The shares were purchased at an average cost of $10.00 per share, for a total transaction of $20,000,000.00. Following the completion of the purchase, the director now owns 1,548,341 shares in the company, valued at $15,483,410. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.March 27, 2024 | markets.businessinsider.comTD Cowen Reaffirms Their Buy Rating on Nkarta (NKTX)March 27, 2024 | msn.comPromising Biopharma Nkarta (NASDAQ:NKTX) Not For the Faint-HeartedMarch 26, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Price Target Increased to $16.00 by Analysts at Canaccord Genuity GroupCanaccord Genuity Group increased their price target on shares of Nkarta from $15.00 to $16.00 and gave the company a "buy" rating in a research report on Tuesday.March 26, 2024 | sg.finance.yahoo.comNkarta, Inc. (NKTX) interactive stock chart – Yahoo FinanceMarch 25, 2024 | seekingalpha.comNkarta: NK Cell Therapy Advancement On Two FrontsMarch 25, 2024 | msn.comNkarta announces pricing of stock offering to raise $240.1MMarch 25, 2024 | markets.businessinsider.comNkarta Prices $240 Mln Offering; Stock Up Over 16%March 25, 2024 | globenewswire.comNkarta Announces Pricing of $240 Million Underwritten OfferingMarch 25, 2024 | markets.businessinsider.comNkarta’s Strategic Pivot to CAR-NK Therapies for Autoimmune Diseases Prompts Buy RatingMarch 23, 2024 | finance.yahoo.comNkarta Inc (NKTX) Posts Full Year 2023 Financial Results: A Focus on NKX019 and Pipeline RealignmentMarch 22, 2024 | finanznachrichten.deNkarta, Inc.: Nkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsMarch 22, 2024 | markets.businessinsider.comBuy Rating for Nkarta: Promising Future for NKX019 in Autoimmune Disease TreatmentMarch 22, 2024 | markets.businessinsider.comNkarta’s Strategic Focus and Financial Strength Underpin Buy RatingMarch 22, 2024 | msn.comThese Analysts Revise Their Forecasts On Nkarta After Q4 ResultsMarch 22, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Given New $25.00 Price Target at MizuhoMizuho dropped their price target on Nkarta from $31.00 to $25.00 and set a "buy" rating on the stock in a research note on Friday.March 22, 2024 | marketbeat.comTrading was temporarily halted for "NKTX" at 09:03 AM with a stated reason of "LULD pause."March 22, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Receives Outperform Rating from Raymond JamesRaymond James reaffirmed an "outperform" rating and issued a $16.00 price target (up previously from $13.00) on shares of Nkarta in a research note on Friday.March 21, 2024 | investorplace.comNKTX Stock Earnings: Nkarta Beats EPS for Q4 2023March 21, 2024 | globenewswire.comNkarta Reports Fourth Quarter and Full Year 2023 Financial Results and Corporate HighlightsMarch 19, 2024 | marketbeat.comNkarta (NASDAQ:NKTX) Stock Price Up 8.4%Nkarta (NASDAQ:NKTX) Trading Up 8.4%March 19, 2024 | markets.businessinsider.comInnovative NK-Cell Therapy: A Buy Rating for Nkarta’s Groundbreaking Approach to Autoimmune DiseasesMarch 19, 2024 | investorplace.com3 Overlooked Stocks Ready to Capture the Market by Storm Get Nkarta News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address AI's Next Magnificent Seven (Ad)The Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years. See His Breakdown of the Seven Stocks You Should Own Here. NKTX Media Mentions By Week NKTX Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NKTX News Sentiment▼1.460.76▲Average Medical News Sentiment NKTX News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NKTX Articles This Week▼02▲NKTX Articles Average Week Get Nkarta News Delivered to You Automatically Sign up to receive the latest news and ratings for NKTX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Fate Therapeutics News Today Phathom Pharmaceuticals News Today MannKind News Today AbCellera Biologics News Today Day One Biopharmaceuticals News Today Mirum Pharmaceuticals News Today Calliditas Therapeutics AB (publ) News Today Collegium Pharmaceutical News Today Enliven Therapeutics News Today Prothena News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NKTX) was last updated on 6/10/2024 by MarketBeat.com Staff From Our PartnersIt's time to ween off Chinese lithium!As the lithium rush continues, this small-cap NASDAQ-traded company may be one of the brightest and most promi...Smallcaps Daily | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredMoonshot Coins for the Current Crypto RunDid you see bitcoin crossed $70k again? Don't miss the next bull run. Because while Bitcoin and Ethereum s...Crypto 101 Media | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | Sponsored